Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery will stimulate physiological changes similar to those in the literature.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
12
For the right/test eye, a defocused image is projected onto the peripheral retina while the subject views a distant, in-focus image
For the left/control eye, no image is projected onto the peripheral retina. The subject views a distant, in-focus image.
Manhattan Vision Associates/institute of Vision Research
New York, New York, United States
Axial length (AL)
Change in AL from baseline in the test eye vs. control eye
Time frame: 1 hour
Choroidal thickness (CT)
Change in CT from baseline in the test eye vs. control eye
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.